Study Information
Study Details
View study details on clinicaltrials.gov.
Locations
Clinical Trial FAQs
Information for patients and study volunteers, including frequently asked questions.
Description
AMPLATZERTM PFO Occluder and AmplatzerTM TalismanTM PFO Occluder Post- Approval Study “PFO PAS” (CRD_806)
The purpose of this single arm, multi-center study is to confirm the safety and effectiveness of the AMPLATZER™ PFO Occluder in the post Approval Setting.
Location: SIMR (Sacramento/Valley Area)
Please contact: SIMR@sutterhealth.org about PFO PAS
Principal Investigator
David K. Roberts, III, M.D., FACC
Co-Investigator(s)
Related Studies
Stupski Serious Illness Program Evaluation
Investigator: Sylvia Sudat, PhD
The Impact of Smoking, Comorbidities, and Race/Ethnicity on COVID-19 Infection and Disease Severity
Investigator: Jiang Li, Ph.D., MPH
Statin Use and Risk Prediction of Atherosclerotic Cardiovascular Disease in Minority Subgroups (SURPASS) Study
Investigators: Jiang Li, Ph.D., MPH, External PI, Principal Investigator
HOMBRE (Hombres con Opciones para Mejorar el Bienestar y bajar el Riesgo de Enfermedades crónicas)
Investigator: Kristen M.J. Azar, R.N., BSN, MSN/MPH
Prevalence, Treatment and Outcomes of Asian Subgroups with Coronary Artery Disease in the U.S.
Investigators: Jiang Li, Ph.D., MPH, External PI, Principal Investigator
Cardiovascular Disease Among Asians and Pacific Islanders (CASPER)
Investigators: Jiang Li, Ph.D., MPH, External PI, Principal Investigator
Advance Care Planning Practices in Caring for Vulnerable Elders with Multiple Chronic Conditions
Culturally Adapted DPP [Diabetes Prevention Program] Intervention for Mexican Americans in Primary Care: An RCT [randomized controlled trial]
Research Aimed at Improving Both Mood and Weight (RAINBOW)
International Study of Comparative Health Effectiveness With Medical and Invasive Approaches (ISCHEMIA)
Investigator: Bob S. Hu, M.D.